Theravance Inc (NASDAQ:THRX)

18.06
Delayed Data
As of Feb 27
 -0.03 / -0.17%
Today’s Change
10.58
Today|||52-Week Range
31.80
+27.63%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Glaxosmithkline Plc
Buy5/09/2014317,770$26.86$8.5M-32.76%
Glaxosmithkline Plc
Buy8/11/2014172,651$22.13$3.8M-18.39%
Shafer Bradford J
General Counsel & Senior Vice President
Sale3/03/201464,006$36.72$2.4M-51.03%
Winningham Rick E
Chief Executive Officer
Sale5/09/201450,225$26.86$1.3M-32.76%
Lee Junning
Senior Vice President-Technical Operations
Sale8/13/201453,424$22.50$1.2M-20.19%
Shafer Bradford J
General Counsel & Senior Vice President
Buy3/03/201465,806$9.69$637.7K-51.03%
Mammen Mathai
Senior VP-Research & Early Clinical Development
Sale5/09/201422,833$26.86$613.3K-32.76%
Shafer Bradford J
General Counsel & Senior Vice President
Sale5/09/201422,833$26.86$613.3K-32.76%
Shafer Bradford J
General Counsel & Senior Vice President
Sale8/11/201427,108$22.12$599.6K-18.39%
Aguiar Michael W
Chief Financial Officer & Senior Vice President
Sale5/09/201421,405$26.86$574.9K-32.76%
Page of 9

To view my watchlist

Not a member yet?

Sign up now for a free account